EFPIA update on the readiness for mandatory use of the Clinical Trials Regulation

A majority of EFPIA members have already submitted at least one clinical trial application through the Clinical Trials Information System (CTIS), the electronic...

EBC & EFPIA hold RETHINKING Alzheimer’s event ahead of policy paper launch

The European Brain Council (EBC), in collaboration with EFPIA, organised a digital event looking at the need to rethink the way we approach detection and...

Europe’s cancer community sets out best practice guide to sustainable, equitable and transformative patient...

Smart investments in cancer care are urgently needed to alleviate demands on healthcare systems and improve access to cancer care

EFPIA response to medicines shortages reports

EFPIA member companies are not reporting shortages as a result of the situation in China, and where necessary have increased supply

Borders should no longer be barriers: The EU-X-CT Multi-stakeholder Initiative

EFGCP and EFPIA launch initiative to enable cross-border access to clinical trials for all patients in Europe

EFPIA update on the readiness for mandatory use of the Clinical Trials Regulation

A majority of EFPIA members have already submitted at least one clinical trial application through the Clinical Trials Information System (CTIS), the electronic...

EBC & EFPIA hold RETHINKING Alzheimer’s event ahead of policy paper launch

The European Brain Council (EBC), in collaboration with EFPIA, organised a digital event looking at the need to rethink the way we approach detection and...

Europe’s cancer community sets out best practice guide to sustainable, equitable and transformative patient...

Smart investments in cancer care are urgently needed to alleviate demands on healthcare systems and improve access to cancer care

EFPIA response to medicines shortages reports

EFPIA member companies are not reporting shortages as a result of the situation in China, and where necessary have increased supply

Borders should no longer be barriers: The EU-X-CT Multi-stakeholder Initiative

EFGCP and EFPIA launch initiative to enable cross-border access to clinical trials for all patients in Europe

 EFPIA response to December EPSCO meeting

Today’s Council meeting provided an informative update on the progress of numerous health-related files and saw the adoption of long-awaited cancer screening...

‘Rare Disease Moonshot’ – Scaling-up public-private partnerships to accelerate research into world’s...

EU-China Biopharmaceutical Innovation Roundtable

Strengthening cooperation and dialogue on health and innovation

Post-code lottery in European diabetes care must be addressed, says EFPIA

Innovation offers the potential to improve health outcomes and quality of life for people living with diabetes. EFPIA is committed to working with all...

EFPIA and Vaccines Europe respond to the European Commission's Global Health Strategy

Key areas identified by the Commission are global issues which no sector can address alone.

European Cancer Pulse: What is your country doing to beat cancer?

New tool provides data on progress in the fight against cancer, revealing disparities within and between EU Member States

Joint Statement Pharmaceutical industry concerns over the implementation of the EU HTA Regulation

We call for a constructive dialogue with the European Commission and the newly established Coordination Group, to ensure the HTA Regulation meets its intended...